drugset / Trial / NCT04425746
Afamelanotide as Adjunctive Therapy in Patients Undergoing Photodynamic Therapy (PDT) Utilising Porfimer Sodium
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study was to evaluate the safety and efficacy of afamelanotide (previously developed as CUV1647) as adjunctive therapy in patients undergoing photodynamic therapy using porfimer sodium.
Timeline
- Start
- 2008-08-05
- Primary completion
- 2009-05-28
- Completion
- 2009-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afamelanotide | Peptide | — | Other |
Indications
No indication recorded.